BACKGROUND It is uncertain whether patients with renal vascular disease will have renal or mortality benefit from re-establishing renal blood flow with renal revascularization procedures. The RAVE study will compare renal revascularization to medical management for people with atherosclerotic renal vascular disease (ARVD) and the indication for revascularization. Patients will be assessed for t...

The antiretroviral therapy is a lifelong use of combination three or more drugs (ARVDs). One the factors contributing to significant decrease in patients’ adherence treatment high toxicity ARVs. aim study safety retrospectively and based on spontaneous reports about adverse drug reactions (ADRs) inputted ARCADe database. Materials method. objects our research were 649 messages ARVDs recorded re...

While the contamination of agroecosystems with pharmaceutical compounds has been reported, fate these compounds, particularly uptake into plants remains unclear. This lack environmental data is evident for a critical class pharmaceuticals, antivirals and antiretrovirals (ARVDs). Thus, this study evaluated root antiretroviral nevirapine, lamivudine efavirenz, antiviral compound oseltamivir in le...

Background: In this article, the author discusses critical appraisals of the major randomized controlled trials on the management of Atherosclerotic Renovascular Disease (ARVD). The article will also discuss the limitations of the published trials, while highlighting the crucial aspect of appropriate patient selection, the serious flaws noted, and the quality of the main studies. Also included ...

UNLABELLED Arrhythmogenic right ventricular dysplasia (ARVD) is both a myocardial disease that predominantly affects the right ventricle (RV) and one of the major causes of sudden death in the young and athletes. A 28-year-old man with no signicant medical history, applied to an emergency department with feeling very ill. After his initial examinations, electrocardiography (ECG) showed ventricu...